We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Research · March 23, 2015

Aqueous Humour Concentrations of VEGF and PEDF With Ranibizumab for Myopic Choroidal Neovascularization

The British Journal of Ophthalmology


Additional Info

The British Journal of Ophthalmology
Effect of Intravitreal Ranibizumab Injections on Aqueous Humour Concentrations of Vascular Endothelial Growth Factor and Pigment Epithelium-Derived Factor in Patients With Myopic Choroidal Neovascularisation
Br J Ophthalmol 2015 Mar 13;[EPub Ahead of Print], C Costagliola, F Semeraro, R dell'Omo, MR Romano, A Russo, F Aceto, R Mastropasqua, A Porcellini

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading